NCT00290394View on ClinicalTrials.gov

Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

rosiglitazone(drug), blood pressure lowering effect

Trial Locations (1)

06490

Baskent University Ankara Hospital, Ankara

All Listed Sponsors
lead

Baskent University

OTHER

NCT00290394 - Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter